IP Library Granted Patent US 9,107,441
Granted Patent B2
US 9,107,441 · App. 13/697,503 · Granted Aug 18, 2015

Composition for reducing absorption of dietary fat

Inventors: Pee Win Chong (Petaling Jaya Selangor, MY); Thomas Hafner (Kuala Lumpur, DE); Istvan Puskas (Hungary, HU)
Assignee: INQPHARM GROUP SDN. BHD.
A23L1/308A23L1/3081A23L1/3082A23L1/3085A61K31/722A61K31/724A61K31/732A61K36/33A23V2002/00A61K31/715
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,107,441
App. No.
13/697,503
Granted
Aug 18, 2015
Kind
B2
Abstract

This invention relates to compositions for reducing the absorption or bioavailability of lipids in the gastrointestinal tract, and to methods for the preparation and use of these compositions. The compositions comprise a source of dietary fiber together with a cyclodextrin. The compositions of the invention are suitable for use in the prevention and treatment of obesity or hyperlipidaemia.

Claims (27)

1. A composition for reducing absorption of dietary fat, comprising

(a) a dietary fibre preparation derived from a plant belonging to the genus Opuntia , and

(b) at least one cyclodextrin, wherein:

(i) the at least one cyclodextrin is present in a sufficient amount such that the fat-binding ability of the dietary fibre preparation is increased relative to a composition comprising the dietary fibre preparation but lacking the at least one cyclodextrin,

(ii) the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and combinations of two or more thereof, and

(iii) the weight ratio of dietary fibre and cyclodextrin is between 95:5 and 60:40.

2. The composition of claim 1 , wherein the dietary fibre preparation is derived from a plant belonging to the family Cactaceae in which the Cactaceae plant belongs to the species Opuntia ficus - indica.

3. The composition of claim 1 wherein the dietary fibre preparation is derived from a plant belonging to the family Cactaceae in which the dietary fibre preparation is derived from cladodes of Opuntia ficus - indica.

4. The composition of claim 1 in which the weight ratio of the dietary fibre and cyclodextrin is between 85:15 and 65:35.

5. The composition of claim 1 further comprising a biologically-active agent for treating obesity.

6. The composition of claim 5 in which the biologically-active agent is selected from the group consisting of absorption-altering, appetite-altering and metabolism-altering agent or combination thereof.

7. The composition of claim 1 further comprising a biologically-active agent for treating hyperlipidaemia.

8. The composition of claim 7 in which the biologically-active agent is selected from the group consisting of cholesterol-lowering agents and combinations thereof.

9. The composition of claim 1 further comprising a nutrient ingredient selected from the group consisting of vitamins and minerals and combinations thereof.

10. A method of reducing weight gain, comprising the step of administering a composition of claim 1 to a subject in need of such treatment.

11. A method of treatment of obesity, comprising the step of administering a composition of claim 1 to a subject in need of such treatment.

12. A method of treatment of hyperlipidaemia, comprising the step of administering a composition of claim 1 to a subject in need of such treatment.

13. A method of increasing the fat-binding ability of a dietary fibre preparation o derived from a plant belonging to the genus Opuntia , the method comprising the step of subjecting the dietary fibre to a physical interaction with a cyclodextrin, wherein:

(i) the at least one cyclodextrin is present in a sufficient amount such that the fat-binding ability of the dietary fibre preparation is increased relative to a composition comprising the dietary fibre preparation but lacking the at least one cyclodextrin,

(ii) the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and combinations of two or more thereof, and

(iii) the weight ratio of dietary fibre and cyclodextrin is between 95:5 and 60:40.

14. A method of increasing the fat-binding ability of a dietary fibre preparation derived from a plant belonging to the genus Opuntia , the method comprising the step of physically mixing the dietary fibre with a cyclodextrin to homogeneity, wherein:

(i) the at least one cyclodextrin is present in a sufficient amount such that the fat-binding ability of the dietary fibre preparation is increased relative to a composition comprising the dietary fibre preparation but lacking the at least one cyclodextrin,

(ii) the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and combinations of two or more thereof, and

(iii) the weight ratio of dietary fibre and cyclodextrin is between 95:5 and 60:40.

15. The composition of claim 1 , wherein the fat-binding ability of the dietary fibre preparation is increased by at least about 10% relative to the composition comprising the dietary fibre preparation but lacking the at least one cyclodextrin.

16. The composition of claim 1 , wherein the dietary fibre comprises approximately equal proportions of insoluble fibre and soluble fibre.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Dec 3, 2021
From: INQPHARM GROUP SDN BHD
To: BIONEXUS LLC
Reel/Frame 058277/0958 →
CHANGE OF NAME Recorded Dec 16, 2013
From: INQPHARM SDN. BHD.
To: INQPHARM GROUP SDN. BHD.
Reel/Frame 031819/0873 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2013
From: CHONG, PEE WIN; HAFNER, THOMAS
To: INQPHARM SDN BHD
Reel/Frame 030586/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2013
From: PUSKAS, ISTVAN
To: CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD.
Reel/Frame 030586/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2013
From: CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LIMITED
To: INQPHARM SDN BHD
Reel/Frame 030586/0959 →
Priority Claims (1)
MY PI 2010002277 · May 14, 2010 · national
Continuity (2)
Provisional Application 61389732 · Oct 5, 2010
Related Publication 20130059817A1 · Mar 7, 2013